It was reported to boston scientific corporation that an orbera365 intragastric balloon system was implanted on (b)(6) 2022.On december 04, 2023, the patient attended sau due to passing blue urine.The patient was discharged the same day, then on (b)(6) 2023 was re-admitted for persistent symptoms.The balloon was removed on an unknown date.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.Note: it was reported that methylene blue was used when filling the orbera balloon.However, according to the instructions for use (ifu) the igb is places in the stomach and filled with sterile saline.Additional it was reported that the patient refused the planned removal on (b)(6) 2023.The patient and physician were aware that device was license for 12 months only, however the balloon was explanted on an unknown date after 12 months.The orbera365 intragastric balloon system directions for use (dfu) states "the maximum placement period for the orbera365 system is 12 months, and it must be removed at that time or earlier.
|